Gene · 9049
NIH grants1,062
NIH grants whose papers are about the gene, through NIH's grant-paper links.
121 to 140 of 1,062
Download this page as JSON| Grant | Title | AIP papers | Newest fiscal year |
|---|---|---|---|
| R01NS081248 | CaMKII Holoenzyme Mechanisms in Opposing Forms of Synaptic Plasticity | 1 | 2025 |
| R01NS117568 | PET/MR Correlates of Accelerated Aging in Chronic Epilepsy | 1 | 2025 |
| R35CA197568 | Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | 1 | 2025 |
| R35CA197623 | Targeting intratumor heterogeneity in breast cancer | 1 | 2025 |
| R35CA231620 | MECHANISMS OF REGULATED CELL DEATH | 1 | 2025 |
| R35GM124868 | Unraveling the Viral Infection Pathway with Virus-locked Observation | 1 | 2025 |
| R35GM133359 | Protein structure and dynamics in ultra-heterogeneous environments-Renewal | 1 | 2025 |
| R35GM139573 | Development of biophysical approaches to investigate high-resolution structure and dynamics of membrane proteins | 1 | 2025 |
| R35GM142588 | Biophysical mechanism and synthetic engineering of optically-controlled Ca2+-powered supramolecular engines | 1 | 2025 |
| R35GM150572 | Understanding the Heterogeneity of Nanoscale Extracellular Vesicles, Exomeres, and Supermeres using Next Generation Optical Nanotweezers | 1 | 2025 |
| R37AI044828 | Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | 1 | 2025 |
| R37HD019938 | Reproductive physiology of gonadotropin synthesis | 1 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 1 | 2025 |
| T32AG023475 | Training in Aging Research | 1 | 2025 |
| T32AG058503 | Infection and Inflammation as Drivers of Aging (IIDA) Predoctoral Training Program | 1 | 2025 |
| T32AI007110 | Basic Microbiology and Infectious Disease | 1 | 2025 |
| T32AI007247 | Cellular and Molecular Mechanisms of Immune Inflammatory Reactions | 1 | 2025 |
| T32AI007511 | Training in Mechanisms of Parasitism | 1 | 2025 |
| T32AR079114 | Regenerative Engineering of Musculoskeletal Tissues- a Convergence Doctoral Training Program | 1 | 2025 |
| T32AT008938 | Predoctoral Training: Innovative Technologies for Natural Products and Integrative Medicine Research | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9049/grants?page=7